Tiziana Life Sciences Operating Income

Tiziana Life Sciences (TLSA) currently reports a operating income of $-37M as of December 2025. That compares with $-24M in the prior-year period — down 53.8% year over year. Use the charts on this page to explore Tiziana Life Sciences's operating income history and peer comparisons.

Tiziana Life Sciences's operating income decreased from $-24M to $-37M — a 53.8% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Tiziana Life Sciences reported $-37M in operating income as of December 2025. That compares with $-24M in the prior-year period — down 53.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-37M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Tiziana Life Sciences, and consider following TLSA for alerts when major investors trade the stock.

Tiziana Life Sciences is classified in the Healthcare sector. On operating income, it currently shows $-37M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TLSA with unrelated industries.